The working group for rare and hereditary kidney diseases, led by Dr. Bodo Beck, has been researching the genetic basis of kidney dysfunction at the Institute of Human Genetics since 2010. This work primarily benefits people affected by rare and hereditary kidney diseases and their families and is carried out in close cooperation with the treating physicians at the children's clinic and other biomedical disciplines. Our working group is an integral part of the Cologne Center for Rare Diseases.

Lab Website

For information about Dr. Beck's and Dr. Erger's research and work, please visit the following page: Institut for Human Genetics

Publication Record on PubMed - Bodo Beck

Publication Record on PubMed - Florian Erger

Publications generated during 1/2023-12/2025 with CMMC affiliation

2024

Kaufeld JK, Kühne L, Schönermarck U, Bräsen JH, von Kaisenberg C, Beck BB, Erger F, Bergmann C, von Bergwelt-Baildon A, Brinkkötter PT, Völker LA, Menne J. Erratum to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition" [Kidney International Reports Volume 9, Issue 4, April 2024, Pages 919-928]. Kidney Int Rep. 2024 Aug 6;9(10):3081. doi: 10.1016/j.ekir.2024.08.001. Erratum for: Kidney Int Rep. 2024 Jan 23;9(4):919-928. doi: 10.1016/j.ekir.2024.01.035. PMID: 39430175; PMCID: PMC11489390.
Deesker LJ, Karacoban HA, Metry EL, Garrelfs SF, Bacchetta J, Boyer O, Collard L, Devresse A, Hayes W, Hulton SA, Martin-Higueras C, Moochhala SH, Neuhaus TJ, Oh J, Prikhodina L, Sikora P, Oosterveld MJS, Groothoff JW, Mandrile G, Beck BB. Intrafamilial Disease Heterogeneity in Primary Hyperoxaluria Type 1. Kidney Int Rep. 2024 Jul 31;9(10):3006-3015. doi: 10.1016/j.ekir.2024.07.026. PMID: 39430166; PMCID: PMC11489452.
Aryal RP, Noel M, Zeng J, Matsumoto Y, Sinard R, Waki H, Erger F, Reusch B, Beck BB, Cummings RD. Cosmc regulates O-glycan extension in murine hepatocytes. Glycobiology. 2024 Aug 30;34(10):cwae069. doi: 10.1093/glycob/cwae069. PMID: 39216105; PMCID: PMC11398974.
Kolbuc M, Kolek MF, Motyka R, Bienias B, Habbig S, Burgmaier K, Prikhodina L, Papizh S, Tasic V, Okorn C, Szczepanska M, Kilis-Pstrusinska K, Wasilewska A, Adamczyk P, Tkaczyk M, Panczyk-Tomaszewska M, Miklaszewska M, Pawlaczyk K, Bukowska-Olech E, Jamsheer A, Jankauskiene A, Konig J, Cheong HI, Ahn YH, Kaspar S, Sikora P, Beck BB, and Zaniew M (2024). Development of a tool for predicting HNF1B mutations in children and young adults with congenital anomalies of the kidneys and urinary tract. Pediatr Nephrol. doi:10.1007/s00467-023-06262-9.
Lamot L, Vuković Brinar I, Fištrek Prlić M, Beck B. Editorial: Cystic kidney diseases in children and adults: from diagnosis to etiology and back. Front Pediatr. 2024 Apr 10;12:1401593. doi: 10.3389/fped.2024.1401593. PMID: 38659695; PMCID: PMC11040088.
Martin-Higueras C, Borghese L, Torres A, Fraga-Bilbao F, Santana-Estupinan R, Stefanidis CJ, Tory K, Walli A, Gondra L, Kempf C, Gessner M, Habbig S, Eifler L, Schmitt CP, Rudel B, Bartram MP, Beck BB, and Hoppe B (2024). Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1. Kidney Int Rep9, 114-133. doi:10.1016/j.ekir.2023.10.004.

Discover more: